3 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1.
Korea Basic Science Institute
Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IXβ Reductase B as a Novel Thrombocytopenia Therapeutic Target.
Korea Basic Science Institute
Compounds and compositions for treating conditions associated with NLRP activity
Novartis